Iridium oxide (IrO) is recognized as a state-of-art catalyst for anodes of low-temperature polymer-electrolyte membrane water electrolyzers (PEMWE), one of the promising clean energy technologies to produce hydrogen, a critical energy carrier for decarbonization. However, typical IrO ink formulations are challenging to process in liquid-film coating processes because of their poor stability against gravitational settling and low viscosities. Here we report on time evolution of the microstructure of concentrated IrO inks in a water-rich dispersion medium, probed using a combination of rheology and X-ray scattering for up to four days.
View Article and Find Full Text PDFCost reduction and fast scale-up of electrolyzer technologies are essential for decarbonizing several crucial branches of industry. For polymer electrolyte water electrolysis, this requires a dramatic reduction of the expensive and scarce iridium-based catalyst, making its efficient utilization a key factor. The interfacial properties between the porous transport layer (PTL) and the catalyst layer (CL) are crucial for optimal catalyst utilization.
View Article and Find Full Text PDFIn situ and micro-scale visualization of electrochemical reactions and multiphase transports on the interface of porous transport electrode (PTE) materials and solid polymer electrolyte (SPE) has been one of the greatest challenges for electrochemical energy conversion devices, such as proton exchange membrane electrolyzer cells (PEMECs), CO reduction electrolyzers, PEM fuel cells, etc. Here, an interface-visible characterization cell (IV-CC) is developed to in situ visualize micro-scaled and rapid electrochemical reactions and transports in PTE/SPE interfaces. Taking the PEMEC of a green hydrogen generator as a study case, the unanticipated local gas blockage, micro water droplets, and their evolution processes are successfully visualized on PTE/PEM interfaces in a practical PEMEC device, indicating the existence of unconventional reactant supply pathways in PEMs.
View Article and Find Full Text PDFChimeric antigen receptor (CAR)-T therapy holds great promise to sustainably improve cancer treatment. However, currently, a broad applicability of CAR-T cell therapies is hampered by limited CAR-T cell versatility and tractability and the lack of exclusive target antigens to discriminate cancerous from healthy tissues. To achieve temporal and qualitative control on CAR-T function, we engineered the Adapter CAR (AdCAR) system.
View Article and Find Full Text PDF